Overview
Description
About
Corrig Road Sandyford Business Park
Zurich, 8001
Latest press releases
New offering provides flexible, cost-effective coverage designed to address rising out-of-pocket costs and deliver peace of mind
MARKHAM, ON, May 13, 2026 /CNW/ -- Combined Canada, a Chubb Benefits Company and leading provider of supplemental accident, health, disability, and life insurance products in Canada, today announced the launch of Combined Cancer Care, a new insurance product designed to help Canadians navigate the financial challenges associated with a cancer diagnosis.
According to the Canadian Medical Association Journal (CMAJ) and reported by the Canadian Cancer Society, an estimated 254,100 Canadians will be diagnosed with cancer in 2026.
With nearly 2 in 5 Canadians expected to develop the disease in their lifetime, cancer remains the leading cause of death in Canada (87,900 projected in 2026). Following a diagnosis, many patients face significant out-of-pocket expenses from prescription drugs and travel for treatment to caregiving and lost income that can place considerable financial strain on individuals and families.
Key features of Combined Cancer Care include:
- Daily benefits for inpatient and outpatient cancer care (up to $400 per day, paid directly)
- Optional lump-sum diagnosis benefits ranging from $2,500 to $10,000
- Coverage options that include heart attack and stroke protection
- Access to Teladoc Health Canada's Expert Medical Services (EMS)
- Multiple policy structures and benefit levels, including palliative care and lifetime coverage options
Benefits can be used for medical and non-medical expenses such as travel, accommodations, home care, and household bills to help the ease of financial pressure during treatment and recovery.
The launch is part of Combined Canada's broader strategy to expand its presence in the supplemental health market and comes amid increased collaboration between medical and enterprise communities to improve outcomes for Canadians navigating cancer and other critical illnesses.
"Cancer doesn't just impact health, it can have a profound financial effect on individuals and their loved ones," said Vincent Iozzo, Chief Distribution Officer at Combined Insurance Canada. "Combined Cancer Care was designed to bridge financial gaps, offering Canadians a simple, affordable way to access funds when they need it most."
Addressing a Growing Financial Burden
A cancer diagnosis costs the average patient nearly $33,000 over their lifetime, with an additional $253 in monthly out-of-pocket expenses. These often-unforeseen costs can negatively impact savings, including retirement. According to the Canadian Cancer Society, nearly 80% of working-age Canadians report concerns about maintaining financial stability or saving for retirement following a diagnosis.
"Customers are looking for solutions that are easy to understand and fit seamlessly into their broader financial plans," added Iozzo. "Combined Cancer Care delivers practical protection that helps ensure a diagnosis doesn't derail someone's financial future, allowing them to focus on getting well."
Combined Cancer Care is designed to provide financial support and complement existing coverage where traditional plans may fall short.
Flexible Coverage Designed for Real Life
Developed in consultation with insurance experts, Combined Cancer Care offers clear, cost-effective protection that can supplement existing coverage and provide financial support for rising cancer-related costs.
"We know that a cancer diagnosis doesn't just affect your health - it can upend every part of your life, including your finances," says Michelle Duggan, VP Partnerships at the Canadian Cancer Society. "We hear every day from people facing unexpected costs while undergoing treatment and recovery. As we continue to advocate for ways to reduce the overall cost of cancer, we recognize how important it is for people to have options that help them manage that financial pressure."
About Combined Canada, a Chubb Benefits Company
Combined Canada, a Chubb Benefits Company, is a leading provider of supplemental accident, health, disability, and life insurance products in Canada. Headquartered in Markham, Ontario, the company has operated in Canada since 1956 as a branch of a Combined Insurance of America. With offices located throughout Canada and sales representatives in every province, Combined Canada is committed to making the world of supplemental insurance easy to understand. The company has an A+ rating by the Better Business Bureau and an A+ (Superior) financial strength rating by AM Best. For more information, please visit www.combined.ca.
About Chubb
Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb employs approximately 45,000 people worldwide. Additional information can be found at: www.chubb.com.
SOURCE Chubb
BOCA RATON, Fla., April 28, 2026 /PRNewswire/ -- Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, and Chubb today announced a strategic alliance focused on enhancing research subject safety, improving data quality, strengthening study integrity, and supporting successful clinical trial outcomes.
Chubb's partnering with Verified Clinical Trials, who offers proprietary subject registry technology, is part of a broader clinical trial risk management approach. VCT's clinical trial subject registry solutions are designed to detect and help prevent duplicate enrollment and other important protocol violations at the time of screening - issues that can compromise research subject safety, affect data quality, create operational and regulatory challenges, and increase the risk of study failure.
Key Benefits of the Alliance Include:
- Enhanced Research Subject Safety: Helping reduce the risk of duplicate or overlapping study participation that may contribute to adverse events, drug interactions, and other safety concerns.
- Improved Data Quality: Supporting cleaner, more reliable study data for stronger analysis, decision-making, and regulatory submissions.
- Greater Study Integrity: Helping reinforce protocol compliance and protect against violations that can undermine trial validity.
- Reduced Risk Exposure: Helping sponsors, CROs, and sites mitigate preventable operational, financial, regulatory, and potential liability risks.
- Stronger Potential for Clinical Trial Success: Supporting better-protected studies with a higher likelihood of meeting research objectives.
- Broader Public Benefit: Helping support the development of safer, more effective drugs and therapies for the patients and communities who rely on them.
Chubb is the leading global underwriter of clinical trials and a longstanding market leader that tailors insurance solutions for life sciences companies, with the scale, expertise, and international capabilities to support pharmaceutical and biotechnology companies ranging from emerging innovators to some of the largest in the world. Chubb clients can benefit from an additional layer of protection against adverse events (AEs), serious adverse events (SAEs), protocol deviations, and compromised data quality associated with duplicate or undisclosed study participation.
By combining Chubb's clinical trial insurance capabilities with VCT's industry-recognized subject registry technology, this alliance is positioned to provide meaningful, additive benefits to sponsors, CROs, research sites, and ultimately research subjects. Together, these complementary services can help reduce preventable risk, improve research subject safety, strengthen protocol compliance, enhance data quality and study integrity, and support more successful clinical trial execution.
"Research subject safety and data integrity are fundamental to every successful clinical trial," said Dr. Mitchell Efros, Co-Founder & CEO at Verified Clinical Trials. "This alliance with Chubb represents an important opportunity to help bring greater protection, stronger oversight, and added value to the clinical research ecosystem. Ultimately, the broader public stands to benefit as well, as safer, more effective drugs and therapies can be developed and brought forward with greater confidence for patient use."
"Chubb is committed to supporting innovative and practical approaches to risk management in clinical research," said Lee Farrow, EVP, Life Sciences Industry Practice Leader at Chubb. "VCT addresses a longstanding and underrecognized challenge in clinical research: the inability to reliably look into a participant's research history to confirm eligibility. This alliance with VCT reflects a shared focus on improving research subject safety, study integrity, and overall trial performance."
"At Verified Clinical Trials, our mission has always been to strengthen the integrity of clinical research while prioritizing the safety of research participants," said Kerri Weingard, Co-Founder, VP and Global COO of Verified Clinical Trials. "This alliance with Chubb represents a meaningful advancement in how the industry approaches risk - moving from reactive to proactive safeguards. By combining VCT's real-time subject verification capabilities with Chubb's global risk management expertise, we are helping to create a more secure, transparent, and reliable clinical trial ecosystem that ultimately benefits sponsors, sites, and, most importantly, patients."
This alliance represents an important step forward in advancing proactive risk management in clinical trials and underscores the value of collaboration between insurers and clinical trial technology leaders working to improve clinical research outcomes worldwide.
About Verified Clinical Trials
Verified Clinical Trials (VCT) is a leading provider of clinical trial subject registry solutions designed to detect and help prevent duplicate enrollment and other protocol violations. Its secure global database is trusted by research sites, sponsors, and CROs to help improve research subject safety, strengthen protocol compliance, and protect data integrity.
About Chubb
Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb employs approximately 45,000 people worldwide. Additional information can be found at: https://www.chubb.com/.
Media Contact:
Justin Goodarz
Chief Commercial Officer
Verified Clinical Trials, LLC
Connect@verifiedclinicaltrials.com
(516) 998-7499
Disclaimer: The non-insurance products and services described herein are provided by Verified Clinical Trials, a third party vendor not affiliated with Chubb. The fact that offers and potential discounts may be made available by this vendor is not an indication that insurance coverage is available under any Chubb policy for any particular incident. Referenced discounts on products and services offered by Verified Clinical Trials are available only to Chubb policyholders with current in-force policies and are subject to applicable insurance laws. For products and services provided, the policyholder and third party vendor would enter into a vendor relationship directly. Chubb will not be involved in the policyholder's decision to purchase services and has no responsibility for services that may be provided.
Logo - https://mma.prnewswire.com/media/2967166/CHUBB_Black_RBG_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/verified-clinical-trials-and-chubb-announce-strategic-alliance-to-advance-research-subject-safety-data-quality-and-clinical-trial-success-302755851.html
